LOADD (Lifestyle Over and Above Drugs in Diabetes) Study

NCT00124553 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2007-03-28

No results posted yet for this study

Summary

In the past, nutritional management formed the cornerstone of treatment of type 2 diabetes (T2DM). More recently, this aspect of treatment has received less attention as drug therapy aimed not only to lower glucose, but also to treat raised blood pressure and blood fats (including cholesterol) has been more widespread. While there is evidence to suggest that blood pressure and blood fat levels have improved, overall diabetes control has not and people with diabetes appear to be becoming progressively more overweight, following trends in the general population. The proposed study involves a randomised controlled trial in which people with T2DM continuing with their regular drug treatment and surveillance, will be randomly allocated to additionally receive intensive advice regarding diet or remain on their usual treatment in this regard. The results will be judged principally in terms of body weight, waist circumference, blood pressure, blood glucose control and blood fats.

Conditions

Interventions

BEHAVIORAL

Intensive dietary advice

Sponsors & Collaborators

  • University of Otago

    collaborator OTHER
  • Edgar National Centre for Diabetes Research

    lead OTHER

Principal Investigators

  • Jim I Mann, FRACP · Edgar National Centre for Diabetes Research

  • Kirsten Coppell, FAFPHM · Edgar National Centre for Diabetes Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Completion
2008-06-30

Countries

  • New Zealand

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00124553 on ClinicalTrials.gov